Your browser doesn't support javascript.
loading
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial.
Ruff, Paul; Van Cutsem, Eric; Lakomy, Radek; Prausova, Jana; van Hazel, Guy A; Moiseyenko, Vladimir M; Soussan-Lazard, Karen; Dochy, Emmanuelle; Magherini, Emmanuelle; Macarulla, Teresa; Papamichael, Demetris.
Affiliation
  • Ruff P; University of Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa. Electronic address: pruff@iafrica.com.
  • Van Cutsem E; University Hospitals Leuven and KU Leuven, Belgium.
  • Lakomy R; Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Prausova J; University Hospital Motol, Prague, Czech Republic.
  • van Hazel GA; University of Western Australia, Western Australia, Australia.
  • Moiseyenko VM; Cancer Center, St-Petersburg, Russian Federation.
  • Soussan-Lazard K; Sanofi, Vitry-sur-Seine, France.
  • Dochy E; Sanofi, Diegem, Belgium.
  • Magherini E; Sanofi, Vitry-sur-Seine, France.
  • Macarulla T; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Papamichael D; Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
J Geriatr Oncol ; 9(1): 32-39, 2018 01.
Article in En | MEDLINE | ID: mdl-28807738

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Camptothecin / Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Geriatr Oncol Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Camptothecin / Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Geriatr Oncol Year: 2018 Document type: Article